The FDA Fast-Tracks Its Review of Psilocybin and Methylone, 2 Promising Psychedelics
Summary
The agency issued "national priority vouchers" for the two drugs six days after President Donald Trump promised to facilitate approval of psychedelic therapies.
Description
The agency issued "national priority vouchers" for the two drugs six days after President Donald Trump promised to facilitate approval of psychedelic therapies.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source